Gefticip Tablet

Gefticip Tablet is indicated for the treatment of non-small cell lung cancer in patients where the cancer has spread to other parts of the body, specifically targeting abnormal epidermal growth factor receptor (EGFR) genes in patients without previous cancer therapy.

Usage and Administration

Gefticip Tablet can be taken with or without food, preferably at the same time each day for consistent results. Always follow the precise dosage and schedule prescribed by your healthcare provider. Do not alter your dosage or discontinue treatment without professional medical guidance.

Key Considerations

Consult with your physician regarding potential side effects, drug interactions, and regular monitoring requirements such as liver function tests. Maintain effective contraception during treatment and avoid use during pregnancy or breastfeeding.

For general reference only and not a substitute for professional medical advice. Use under the guidance of a qualified healthcare professional; always read the label and consult your doctor or pharmacist on suitability, dosage, and interactions.